Follow-on Biologics Market Report

Global Follow-on Biologics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：148
  • REPORT CODE：GMM862608
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Follow-on Biologics market report explains the definition, types, applications, major countries, and major players of the Follow-on Biologics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Samsung Biologics

    • Biocon

    • Teva Pahrmaceutical

    • Amgen

    • Stada Arzneimittel AG

    • Celltrion

    • Dr Reddy's Laboratories

    • Pfizer

    • Sandoz

    • Mylan

    By Type:

    • Recombinant Non-glycosylated Proteins

    • Recombinant Glycosylated Proteins

    • Recombinant Peptides

    By End-User:

    • Oncology

    • Blood Disorders

    • Chronic Diseases

    • Autoimmune Diseases

    • Growth Hormone Deficiency

    • Infectious Diseases

    • Other Diseases

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Follow-on Biologics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Follow-on Biologics Outlook to 2028- Original Forecasts

    • 2.2 Follow-on Biologics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Follow-on Biologics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Follow-on Biologics Market- Recent Developments

    • 6.1 Follow-on Biologics Market News and Developments

    • 6.2 Follow-on Biologics Market Deals Landscape

    7 Follow-on Biologics Raw Materials and Cost Structure Analysis

    • 7.1 Follow-on Biologics Key Raw Materials

    • 7.2 Follow-on Biologics Price Trend of Key Raw Materials

    • 7.3 Follow-on Biologics Key Suppliers of Raw Materials

    • 7.4 Follow-on Biologics Market Concentration Rate of Raw Materials

    • 7.5 Follow-on Biologics Cost Structure Analysis

      • 7.5.1 Follow-on Biologics Raw Materials Analysis

      • 7.5.2 Follow-on Biologics Labor Cost Analysis

      • 7.5.3 Follow-on Biologics Manufacturing Expenses Analysis

    8 Global Follow-on Biologics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Follow-on Biologics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Follow-on Biologics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Follow-on Biologics Market Outlook by Types and Applications to 2022

    • 9.1 Global Follow-on Biologics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Recombinant Non-glycosylated Proteins Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Recombinant Glycosylated Proteins Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Recombinant Peptides Consumption and Growth Rate (2017-2022)

    • 9.2 Global Follow-on Biologics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Growth Hormone Deficiency Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Other Diseases Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Follow-on Biologics Market Analysis and Outlook till 2022

    • 10.1 Global Follow-on Biologics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Follow-on Biologics Consumption (2017-2022)

      • 10.2.2 Canada Follow-on Biologics Consumption (2017-2022)

      • 10.2.3 Mexico Follow-on Biologics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Follow-on Biologics Consumption (2017-2022)

      • 10.3.2 UK Follow-on Biologics Consumption (2017-2022)

      • 10.3.3 Spain Follow-on Biologics Consumption (2017-2022)

      • 10.3.4 Belgium Follow-on Biologics Consumption (2017-2022)

      • 10.3.5 France Follow-on Biologics Consumption (2017-2022)

      • 10.3.6 Italy Follow-on Biologics Consumption (2017-2022)

      • 10.3.7 Denmark Follow-on Biologics Consumption (2017-2022)

      • 10.3.8 Finland Follow-on Biologics Consumption (2017-2022)

      • 10.3.9 Norway Follow-on Biologics Consumption (2017-2022)

      • 10.3.10 Sweden Follow-on Biologics Consumption (2017-2022)

      • 10.3.11 Poland Follow-on Biologics Consumption (2017-2022)

      • 10.3.12 Russia Follow-on Biologics Consumption (2017-2022)

      • 10.3.13 Turkey Follow-on Biologics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Follow-on Biologics Consumption (2017-2022)

      • 10.4.2 Japan Follow-on Biologics Consumption (2017-2022)

      • 10.4.3 India Follow-on Biologics Consumption (2017-2022)

      • 10.4.4 South Korea Follow-on Biologics Consumption (2017-2022)

      • 10.4.5 Pakistan Follow-on Biologics Consumption (2017-2022)

      • 10.4.6 Bangladesh Follow-on Biologics Consumption (2017-2022)

      • 10.4.7 Indonesia Follow-on Biologics Consumption (2017-2022)

      • 10.4.8 Thailand Follow-on Biologics Consumption (2017-2022)

      • 10.4.9 Singapore Follow-on Biologics Consumption (2017-2022)

      • 10.4.10 Malaysia Follow-on Biologics Consumption (2017-2022)

      • 10.4.11 Philippines Follow-on Biologics Consumption (2017-2022)

      • 10.4.12 Vietnam Follow-on Biologics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Follow-on Biologics Consumption (2017-2022)

      • 10.5.2 Colombia Follow-on Biologics Consumption (2017-2022)

      • 10.5.3 Chile Follow-on Biologics Consumption (2017-2022)

      • 10.5.4 Argentina Follow-on Biologics Consumption (2017-2022)

      • 10.5.5 Venezuela Follow-on Biologics Consumption (2017-2022)

      • 10.5.6 Peru Follow-on Biologics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Follow-on Biologics Consumption (2017-2022)

      • 10.5.8 Ecuador Follow-on Biologics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Follow-on Biologics Consumption (2017-2022)

      • 10.6.2 Kuwait Follow-on Biologics Consumption (2017-2022)

      • 10.6.3 Oman Follow-on Biologics Consumption (2017-2022)

      • 10.6.4 Qatar Follow-on Biologics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Follow-on Biologics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Follow-on Biologics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Follow-on Biologics Consumption (2017-2022)

      • 10.7.2 South Africa Follow-on Biologics Consumption (2017-2022)

      • 10.7.3 Egypt Follow-on Biologics Consumption (2017-2022)

      • 10.7.4 Algeria Follow-on Biologics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Follow-on Biologics Consumption (2017-2022)

      • 10.8.2 New Zealand Follow-on Biologics Consumption (2017-2022)

    11 Global Follow-on Biologics Competitive Analysis

    • 11.1 Samsung Biologics

      • 11.1.1 Samsung Biologics Company Details

      • 11.1.2 Samsung Biologics Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Samsung Biologics Follow-on Biologics Main Business and Markets Served

      • 11.1.4 Samsung Biologics Follow-on Biologics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Biocon

      • 11.2.1 Biocon Company Details

      • 11.2.2 Biocon Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Biocon Follow-on Biologics Main Business and Markets Served

      • 11.2.4 Biocon Follow-on Biologics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Teva Pahrmaceutical

      • 11.3.1 Teva Pahrmaceutical Company Details

      • 11.3.2 Teva Pahrmaceutical Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Teva Pahrmaceutical Follow-on Biologics Main Business and Markets Served

      • 11.3.4 Teva Pahrmaceutical Follow-on Biologics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Amgen

      • 11.4.1 Amgen Company Details

      • 11.4.2 Amgen Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Amgen Follow-on Biologics Main Business and Markets Served

      • 11.4.4 Amgen Follow-on Biologics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Stada Arzneimittel AG

      • 11.5.1 Stada Arzneimittel AG Company Details

      • 11.5.2 Stada Arzneimittel AG Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Stada Arzneimittel AG Follow-on Biologics Main Business and Markets Served

      • 11.5.4 Stada Arzneimittel AG Follow-on Biologics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Celltrion

      • 11.6.1 Celltrion Company Details

      • 11.6.2 Celltrion Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Celltrion Follow-on Biologics Main Business and Markets Served

      • 11.6.4 Celltrion Follow-on Biologics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Dr Reddy's Laboratories

      • 11.7.1 Dr Reddy's Laboratories Company Details

      • 11.7.2 Dr Reddy's Laboratories Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Dr Reddy's Laboratories Follow-on Biologics Main Business and Markets Served

      • 11.7.4 Dr Reddy's Laboratories Follow-on Biologics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer

      • 11.8.1 Pfizer Company Details

      • 11.8.2 Pfizer Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Follow-on Biologics Main Business and Markets Served

      • 11.8.4 Pfizer Follow-on Biologics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sandoz

      • 11.9.1 Sandoz Company Details

      • 11.9.2 Sandoz Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sandoz Follow-on Biologics Main Business and Markets Served

      • 11.9.4 Sandoz Follow-on Biologics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Mylan

      • 11.10.1 Mylan Company Details

      • 11.10.2 Mylan Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Mylan Follow-on Biologics Main Business and Markets Served

      • 11.10.4 Mylan Follow-on Biologics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Follow-on Biologics Market Outlook by Types and Applications to 2028

    • 12.1 Global Follow-on Biologics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Recombinant Non-glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Recombinant Glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Follow-on Biologics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Chronic Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Growth Hormone Deficiency Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Follow-on Biologics Market Analysis and Outlook to 2028

    • 13.1 Global Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.2 UK Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.5 France Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.3 India Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Follow-on Biologics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Follow-on Biologics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Follow-on Biologics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Follow-on Biologics

    • Figure of Follow-on Biologics Picture

    • Table Global Follow-on Biologics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Follow-on Biologics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Recombinant Non-glycosylated Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Glycosylated Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Peptides Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormone Deficiency Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Other Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Follow-on Biologics Consumption by Country (2017-2022)

    • Table North America Follow-on Biologics Consumption by Country (2017-2022)

    • Figure United States Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Canada Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table Europe Follow-on Biologics Consumption by Country (2017-2022)

    • Figure Germany Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure UK Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Spain Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure France Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Italy Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Finland Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Norway Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Poland Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Russia Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table APAC Follow-on Biologics Consumption by Country (2017-2022)

    • Figure China Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Japan Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure India Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table South America Follow-on Biologics Consumption by Country (2017-2022)

    • Figure Brazil Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Chile Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Peru Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table GCC Follow-on Biologics Consumption by Country (2017-2022)

    • Figure Bahrain Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Oman Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table Africa Follow-on Biologics Consumption by Country (2017-2022)

    • Figure Nigeria Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table Oceania Follow-on Biologics Consumption by Country (2017-2022)

    • Figure Australia Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Follow-on Biologics Consumption and Growth Rate (2017-2022)

    • Table Samsung Biologics Company Details

    • Table Samsung Biologics Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samsung Biologics Follow-on Biologics Main Business and Markets Served

    • Table Samsung Biologics Follow-on Biologics Product Portfolio

    • Table Biocon Company Details

    • Table Biocon Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Follow-on Biologics Main Business and Markets Served

    • Table Biocon Follow-on Biologics Product Portfolio

    • Table Teva Pahrmaceutical Company Details

    • Table Teva Pahrmaceutical Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pahrmaceutical Follow-on Biologics Main Business and Markets Served

    • Table Teva Pahrmaceutical Follow-on Biologics Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Follow-on Biologics Main Business and Markets Served

    • Table Amgen Follow-on Biologics Product Portfolio

    • Table Stada Arzneimittel AG Company Details

    • Table Stada Arzneimittel AG Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel AG Follow-on Biologics Main Business and Markets Served

    • Table Stada Arzneimittel AG Follow-on Biologics Product Portfolio

    • Table Celltrion Company Details

    • Table Celltrion Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Follow-on Biologics Main Business and Markets Served

    • Table Celltrion Follow-on Biologics Product Portfolio

    • Table Dr Reddy's Laboratories Company Details

    • Table Dr Reddy's Laboratories Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Follow-on Biologics Main Business and Markets Served

    • Table Dr Reddy's Laboratories Follow-on Biologics Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Follow-on Biologics Main Business and Markets Served

    • Table Pfizer Follow-on Biologics Product Portfolio

    • Table Sandoz Company Details

    • Table Sandoz Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Follow-on Biologics Main Business and Markets Served

    • Table Sandoz Follow-on Biologics Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Follow-on Biologics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Follow-on Biologics Main Business and Markets Served

    • Table Mylan Follow-on Biologics Product Portfolio

    • Figure Global Recombinant Non-glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Glycosylated Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Peptides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormone Deficiency Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Table North America Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure United States Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure Germany Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure China Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Follow-on Biologics Consumption Forecast by Country (2022-2028)

    • Figure Australia Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Follow-on Biologics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US